This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 26238 results found since Jan 2013.
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Condition: Rhabdomyosarcoma Interventions: Drug: Vincristine; Drug: Dactinomycin; Drug: Cyclophosphamide; Procedure: Surgical Resection; Procedure: Proton beam radiation or external beam radiation or brachytherapy; Drug: Liposomal irinotecan; Drug: Vinorelbine; Drug: Temozolomide; Drug: Filgrastim, peg- filgrastim Sponsor: St. Jude Children's Research Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 4, 2023 Category: Research Source Type: clinical trials
Intensity Modulated Radiation Therapy Alone Vs Intensity Modulated Radiation Therapy and Brachytherapy for T1-T2N0M0 Oropharyngeal Cancers: Results from A Randomized Controlled Trial
To compare clinical outcomes of intensity modulated radiation therapy (IMRT) alone vs IMRT+ brachytherapy (BT) in patients with T1-T2N0M0 oropharyngeal squamous cell cancers (OPSCC).
Source: International Journal of Radiation Oncology * Biology * Physics - September 1, 2023 Category: Radiology Authors: Ashwini Budrukkar, Vedang Murthy, Sheetal Kashid, Monali Swain, Venkatesh Rangarajan, Sarbani Ghosh Laskar, Sadhana Kannan, Shrikant Kale, Rituraj Upreti, Prathamesh Pai, Gouri Pantvaidya, Tejpal Gupta, Jai Prakash Agarwal Tags: Clinical Investigation Source Type: research
Table of Contents
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Source Type: research
Masthead
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Source Type: research
Editorial Board
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Source Type: research
Boundary delineation in transrectal ultrasound images for region of interest of prostate
Phys Med Biol. 2023 Aug 31. doi: 10.1088/1361-6560/acf5c5. Online ahead of print.ABSTRACTAccurate and robust prostate segmentation in transrectal ultrasound (TRUS) images is of great interest for ultrasound-guided brachytherapy for prostate cancer. However, the current practice of manual segmentation is difficult, time-consuming, and prone to errors. To overcome these challenges, we developed an accurate prostate segmentation framework (A-ProSeg) for TRUS images. The proposed segmentation method includes three innovation steps: (1) acquiring the sequence of vertices by using an improved polygonal segment-based method with...
Source: Physics in Medicine and Biology - August 31, 2023 Category: Physics Authors: Tao Peng Yan Dong Gongye Di Jing Zhao Tian Li Ge Ren Lei Zhang Jing Cai Source Type: research
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
CONCLUSIONS: Dose-escalated radiotherapy by BT did not negatively impact long-term adverse effects, substantial problems or QoL compared with EBRT. Future randomised studies using improved EBRT techniques are needed.PMID:37644904 | DOI:10.2340/sju.v58.9571
Source: Scandinavian Journal of Urology - August 30, 2023 Category: Urology & Nephrology Authors: Trude B Wedde Milada C Smaastuen Kari Vatne Melanie Birthe Schulz-Jaavall Sophie D Foss å Wolfgang Lh Lilleby Source Type: research
Locally recurrent prostate cancer with RB1/TP53 alterations successfully treated by salvage focal brachytherapy: a case report
Am J Clin Exp Urol. 2023 Aug 15;11(4):339-343. eCollection 2023.ABSTRACTRetinoblastoma transcriptional corepressor 1 (RB1) and tumor protein p53 (TP53) are well-known tumor suppressor genes; their alterations are associated with poor prognosis in human malignancies and quite rare in locally recurrent cases. The patient was a 58-year-old man who was diagnosed with cT1cN0M0 prostate cancer with Gleason score of 3+3=6 and underwent brachytherapy as the initial treatment. Local recurrence was detected in the left lobe of the prostate 154 months later and whole-exome sequencing that was performed at the request of the patient r...
Source: Clinical Prostate Cancer - August 30, 2023 Category: Cancer & Oncology Authors: Takahiro Komori Takeo Kosaka Tomoki Tanaka Keitaro Watanabe Yota Yasumizu Shuji Mikami Mototsugu Oya Source Type: research
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
CONCLUSIONS: Dose-escalated radiotherapy by BT did not negatively impact long-term adverse effects, substantial problems or QoL compared with EBRT. Future randomised studies using improved EBRT techniques are needed.PMID:37644904 | DOI:10.2340/sju.v58.9571
Source: Scandinavian Journal of Urology - August 30, 2023 Category: Urology & Nephrology Authors: Trude B Wedde Milada C Smaastuen Kari Vatne Melanie Birthe Schulz-Jaavall Sophie D Foss å Wolfgang Lh Lilleby Source Type: research
Locally recurrent prostate cancer with RB1/TP53 alterations successfully treated by salvage focal brachytherapy: a case report
Am J Clin Exp Urol. 2023 Aug 15;11(4):339-343. eCollection 2023.ABSTRACTRetinoblastoma transcriptional corepressor 1 (RB1) and tumor protein p53 (TP53) are well-known tumor suppressor genes; their alterations are associated with poor prognosis in human malignancies and quite rare in locally recurrent cases. The patient was a 58-year-old man who was diagnosed with cT1cN0M0 prostate cancer with Gleason score of 3+3=6 and underwent brachytherapy as the initial treatment. Local recurrence was detected in the left lobe of the prostate 154 months later and whole-exome sequencing that was performed at the request of the patient r...
Source: Clinical Prostate Cancer - August 30, 2023 Category: Cancer & Oncology Authors: Takahiro Komori Takeo Kosaka Tomoki Tanaka Keitaro Watanabe Yota Yasumizu Shuji Mikami Mototsugu Oya Source Type: research
